Michaela Liedtke: Clinical Trials

1 trial sponsored by Michaela Liedtke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Michaela Liedtke: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
Amrubicin, Lenalidomide, Dexamethasone - Multiple Myeloma
Phase 1 / Phase 2CompletedMichaela Liedtke142011-08-012018-09-18

Conditions studied

Multiple Myeloma (1)

Interventions

Aspirin (1)  ·  Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Lenalidomide (1)  ·  amrubicin (1)  ·  pegfilgrastim (1)

Countries

United States (1)

Results publications

PMID 29802551